Article
DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 2016
Hanaford Allison R, Archer Tenley C, Price Antoinette, Kahlert Ulf D, Maciaczyk Jarek, Nikkhah Guido, Kim Jong Wook, Ehrenberger Tobias, Clemons Paul A, Dančík Vlado, Seashore-Ludlow Brinton, Viswanathan Vasanthi, Stewart Michelle L, Rees Matthew G, Shamji Alykhan, Schreiber Stuart, Fraenkel Ernest, Pomeroy Scott L, Mesirov Jill P, Tamayo Pablo, Eberhart Charles G, Raabe Eric H
Abstract excerpt
PURPOSE: We used human stem and progenitor cells to develop a genetically accurate novel model of MYC-driven Group 3 medulloblastoma. We also developed a new informatics method, Disease-model Signature versus Compound-Variety Enriched Response ("DiSCoVER"), to identify novel therapeutics that target this specific disease subtype. EXPERIMENTAL DESIGN: Human neural stem and progenitor cells derived from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
